Fragment ID |
Section Title |
Text |
In Table? |
In List? |
_1 |
General Information About Adult Acute Lymphoblastic Leukemia (ALL) |
General Information About Adult Acute Lymphoblastic Leukemia |
|
|
_58 |
Stage Information for Adult ALL |
Disease Status |
X |
|
_87 |
Remission induction therapy |
Remission induction therapy |
X |
|
_87 |
Remission induction therapy |
Remission induction therapy |
|
X |
_101 |
CNS prophylaxis therapy |
CNS prophylaxis therapy |
X |
|
_101 |
CNS prophylaxis therapy |
Central nervous system (CNS) prophylaxis therapy |
|
X |
_111 |
Postremission therapy |
Postremission therapy |
X |
|
_111 |
Postremission therapy |
Postremission therapy |
|
X |
_130 |
CNS prophylaxis therapy |
CNS prophylaxis therapy |
X |
|
_130 |
CNS prophylaxis therapy |
Central nervous system (CNS) prophylaxis therapy |
|
X |
_139 |
Reinduction chemotherapy |
Reinduction chemotherapy |
X |
|
_139 |
Reinduction chemotherapy |
Reinduction chemotherapy |
|
X |
_141 |
Palliative radiation therapy |
Palliative radiation therapy |
X |
|
_141 |
Palliative radiation therapy |
Palliative radiation therapy |
|
X |
_143 |
Dasatinib |
Dasatinib |
X |
|
_143 |
Dasatinib |
Dasatinib |
|
X |
_222 |
Cellular Classification of Adult ALL |
None |
|
|
_228 |
Incidence and Mortality |
statistics |
|
|